Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,926 | -80,290 | -42,266 | -126,780 | -93,855 |
| Depreciation Amortization | 11,110 | 5,960 | 2,199 | 4,024 | 2,906 |
| Other Working Capital | 120,853 | -6,009 | -7,254 | -3,719 | 3,868 |
| Other Operating Activity | 9,806 | 6,795 | 3,766 | 12,568 | 9,643 |
| Operating Cash Flow | $164,695 | $-73,544 | $-43,555 | $-113,907 | $-77,438 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 86,922 | 89,210 | 28,636 | 2,360 | -48,025 |
| PPE Investments | -364 | -271 | -176 | -1,754 | -1,346 |
| Investing Cash Flow | $86,558 | $88,939 | $28,460 | $606 | $-49,371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,366 | 2,453 | 1,952 | 5,673 | 4,545 |
| Other Financing Activity | -1,476 | -446 | 0 | 0 | 0 |
| Financing Cash Flow | $1,890 | $2,007 | $1,952 | $5,673 | $4,545 |
| Beginning Cash Position | 68,114 | 68,114 | 68,114 | 175,742 | 175,742 |
| End Cash Position | 321,257 | 85,516 | 54,971 | 68,114 | 53,478 |
| Net Cash Flow | $253,143 | $17,402 | $-13,143 | $-107,628 | $-122,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | 164,695 | -73,544 | -43,555 | -113,907 | -77,438 |
| Capital Expenditure | -364 | -271 | -176 | -1,754 | -1,346 |
| Free Cash Flow | 164,331 | -73,815 | -43,731 | -115,661 | -78,784 |